Ex-ESPN star John Brenkus' cause of death revealed after passing away last week at 54
Former ESPN host and best-selling author John Brenkus died from suicide, a medical examiner has confirmed.
TMZ said that the Virginia Department of Health, Office of the Chief Medical Examiner confirmed the tragic nature of the 54-year-old's death last week.
When the Brenkus family announced the news of his passing on Sunday, they alluded to the nature of his death by saying he had been fighting depression.
The statement said: 'It is with profound sadness that we share the news that John Brenkus has passed away.
'John, co-founder of Base Productions, Founder of Brinx.TV, and co-creator and host of the six-time Emmy award-winning "Science," had been battling depression.
'John lost his fight with this terrible illness on May 31, 2025. His heartbroken family and friends request privacy at this time, and encourage anyone who is struggling with depression to seek help.'
Back in January 2023, during an interview with ex-NFL player Marcellus Wiley, Brenkus opened up on his mental health struggles. 'I fell into a very deep depression,' he said.
'I spiraled into a deep, deep depression and I was flat-out suicidal.' Brenkus revealed that his dog saved his life.
'(He) came to my rescue... and in my suicidal funk, I was like: "What am I doing?" I literally picked up my phone, called my mom and said: "There's something wrong with me. I am mentally lost."'
Brenkus then detailed his 'battle' for 'answers' which involved seeing multiple different psychologists and psychiatrists.
Back in 2010, he wrote 'The Perfection Point: Sport Science Predicts the Fastest Man, the Highest Jump, and the Limits of Athletic Performance'.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Guardian
7 minutes ago
- The Guardian
Alzheimer's blood test can spot people with early symptoms, study suggests
A new blood test for Alzheimer's disease can accurately detect people with early symptoms, research suggests. Experts from the Mayo Clinic in the US have provided further evidence that blood tests can work to accurately diagnose dementia by examining two proteins in blood plasma. The proteins – amyloid beta 42/40 and p-tau217 – are associated with amyloid plaque buildup, which is a hallmark of Alzheimer's disease. Researchers found the blood test was highly accurate, with 95% sensitivity, which means it was 95% accurate in picking up people with memory problems, with very few cases missed. It was also 82% for specificity, which means it was also highly accurate in ruling out people without dementia. The study was carried out on more than 500 people in an outpatient memory clinic, meaning it is real-world data. The blood test has been approved by the Food and Drug Administration regulator in the US. Dr Gregg Day, who led the study in the journal Alzheimer's and Dementia, said the test was as good as more invasive tests in use. 'Our study found that blood testing affirmed the diagnosis of Alzheimer's disease with 95% sensitivity and 82% specificity,' he said. 'When performed in the outpatient clinical setting, this is similar to the accuracy of cerebrospinal fluid biomarkers of the disease and is much more convenient and cost-effective.' Overall, researchers found that p-tau217 levels were higher in patients with Alzheimer's disease versus those without the disease. Day said the next steps in the research were to evaluate blood-based testing in more diverse patient populations and people with early Alzheimer's who showed no cognitive symptoms. Dr Richard Oakley, associate director for research and innovation at the Alzheimer's Society in the UK, said the results 'suggest this test is very accurate' and could be used alongside other tests and observations from a trained health professional. 'This study shows how blood tests are making diagnosis of Alzheimer's disease quicker, easier and more accessible than ever before in a real-world setting,' he added. 'While focused on Alzheimer's disease, the test was evaluated in people with other types of dementias too, showing that it may help with differentiate causes of cognitive decline, though more research in diverse groups of individuals and in community-based setting is still needed. 'Currently diagnosis options in the UK are often slow, expensive and can be invasive, meaning thousands miss out on the benefits one can bring. 'It's great to see blood tests like this approved for clinical use in the US. We hope to see the same in the NHS, which is why we're part of the Blood Biomarker Challenge.' The Blood Biomarker Challenge is a multimillion-pound research programme supported by the Alzheimer's Society, Alzheimer's Research UK and the National Institute for Health and Care Research. Its goal is to bring blood tests for dementia diagnosis to the National Health Service by 2029. Oakley said: 'Blood tests will be critical to accelerate diagnosis and give more people access to the care, support and treatments they desperately need faster than ever before. 'We must see long-term investment in the tools and workforce needed to ensure everyone living with dementia can get an early an accurate diagnosis, which is even more important with disease-modifying treatments on the horizon.' Dr Julia Dudley, head of research at Alzheimer's Research UK, said: 'We urgently need to improve how we diagnose dementia and it's great to see international research working towards this goal. 'Blood tests in this study look at p-tau217 and amyloid beta 42/40 and showed the tests offered high accuracy in confirming Alzheimer's disease. 'This study adds to the growing evidence that blood tests can detect the diseases that cause dementia in people with early memory and thinking problems. 'An important point to consider is that people taking part in research don't always reflect the full diversity of those affected by dementia, who might have additional conditions or other characteristics. 'That is why work is needed to understand whether these blood tests work in a real-world setting. 'In the UK, studies like the Blood Biomarker Challenge are helping to build this evidence. The study is testing blood tests, including p-tau217, in thousands of people from sites across the UK. 'This work will be a crucial part of making diagnosis easier and faster, which will bring us closer to a cure.'
Reuters
24 minutes ago
- Reuters
Angels' bullpen locks up victory over Mariners
June 7 - Nolan Schanuel's RBI single in the fifth inning gave the Los Angeles Angels their first lead of the night, and three scoreless innings by the bullpen finished off a 5-4 victory over the Seattle Mariners on Friday in Anaheim, Calif. Travis d'Arnaud had two hits, including a two-run homer, and Chris Taylor singled, doubled and drove in a run to lead the Angels' offense, helping give starting pitcher Kyle Hendricks the 100th victory of his career. Hendricks (3-6) yielded four runs on eight hits in six innings. He struck out two and walked two. The Angels got one hitless inning apiece from Ryan Zeferjahn, Reid Detmers and Kenley Jansen (13th save). The trio combined to allow just one walk while striking out three. Seattle starter Bryce Miller (2-5) permitted five runs on six hits and a walk in five innings. He fanned two. The Mariners opened the scoring against Hendricks in the third inning on an RBI single by J.P. Crawford, but the Angels matched it in their half of the third on an RBI single by Zach Neto off Miller. The Mariners regained the lead in the top of the fourth after loading the bases with no outs. Rowdy Tellez drove in the first run of the inning with a sacrifice fly to deep right field, with Jorge Soler making the catch just in front of the short fence near the right field foul pole. The second run of the inning scored when Leody Taveres grounded out, bringing in Cal Raleigh from third to give the Mariners a 3-1 lead. The Angels matched it again in the bottom of the fourth on d'Arnaud's two-run homer, tying the game at 3-3. The Mariners again took the lead at 4-3 in the fifth, getting a two-out RBI triple from Julio Rodriguez. Angels center fielder Jo Adell lost his glove over the fence trying to make the catch. The Angels responded again in the bottom of the fifth, getting an RBI double from Taylor and an RBI single from Schanuel for a 5-4 edge. Taylor just missed out on his third hit of the game in the sixth inning, but Rodriguez made a leaping catch at the fence in center field, robbing a home run. --Field Level Media
Reuters
40 minutes ago
- Reuters
Sonny Gray, Cardinals blank Dodgers in series opener
June 7 - Sonny Gray and three relievers combined on a shutout as the St. Louis Cardinals beat the visiting Los Angeles Dodgers 5-0 Friday night. Gray (7-1) worked 6 1/3 innings, allowing eight hits while striking out five and walking none. JoJo Romero, Phil Maton and Steven Matz took it from there, and Los Angeles finished 1-for-13 with runners in scoring position. Pedro Pages hit a two-run homer and Willson Contreras added a solo shot for the Cardinals. Brendan Donovan hit a two-run single, and Nolan Arenado went 3-for-4 with a run. Dodgers starter Justin Wrobleski (1-2) permitted four runs on six hits and three walks in six innings. He struck out five. By taking the opener of a three-game series, St. Louis won for just the second time in five games. Los Angeles took its fourth defeat in six games. After rain delayed the start for 1 hour, 17 minutes, Mookie Betts hit a one-out double in the first inning. However, Gray struck out Freddie Freeman and retired Teoscar Hernandez on a groundout. The Dodgers threatened again in the second inning. Andy Pages and Michael Conforto hit one-out singles before Gray retired the next two batters. The Cardinals took a 2-0 lead in their half of the inning on a single by Arenado and Pedro Pages' fifth homer of the season. Gray escaped trouble again in the third inning, retiring three straight hitters after Shohei Ohtani and Betts hit singles to open the frame. St. Louis increased its margin to 4-0 in the fifth inning. Wrobleski walked Pedro Pages and Lars Nootbaar, and a groundout advanced the runners before Donovan hit a two-out, two-run single to center. Gray retired 10 straight batters before Hernandez hit a one-out double in the sixth inning. Andy Pages reached on a two-out infield single, but Conforto popped out to end the threat. Betts led off the eighth inning with a single and went to third on Freeman's double. Maton relieved Romero and shut down the rally, striking out Hernandez and Max Muncy before getting Andy Pages ground out. Contreras homered in the eighth inning, his seventh of the year, to make it 5-0. --Field Level Media
